Skip to main content
Top
Published in: Clinical Rheumatology 5/2016

01-05-2016 | Original Article

Cardiac autonomic functions in children with familial Mediterranean fever

Authors: Murat Şahin, Mustafa Kır, Balahan Makay, Pembe Keskinoğlu, Elçin Bora, Erbil Ünsal, Nurettin Ünal

Published in: Clinical Rheumatology | Issue 5/2016

Login to get access

Abstract

Familial Mediterranean fever (FMF) is the most common inherited autoinflammatory disease in the world. The long-term effects of subclinical inflammation in FMF are not well recognized. Some studies have suggested that FMF is associated with cardiac autonomic dysfunction in adult FMF patients. The objective of this study was to investigate the cardiac autonomic functions in pediatric FMF patients by using several autonomic tests. Thirty-five patients with FMF and 35 healthy controls were enrolled in this cross-sectional study. Demographic data, disease-specific data, and orthostatic symptoms were recorded. In all participants, 12-lead electrocardiography (ECG), 24 h ambulatory electrocardiographic monitoring, transthoracic echocardiography, treadmill exercise test, and head upright tilt-table (HUTT) test were performed. The heart rate recovery (HRR) indices of the two groups were similar. Also, chronotropic response was similar in both groups. The time-domain parameters of heart rate variability (HRV) were similar in both groups, except mean RR (p = 0.024). Frequencies of ventricular and supraventricular ectopic stimuli were similar in both groups. There were no statistically significant differences between the groups in average QT and average corrected QT interval length, average QT interval dispersion, and average QT corrected dispersion. There was no significant difference between the two groups regarding the ratio of clinical dysautonomic reactions on HUTT. However, we observed a significantly higher rate of dysautonomic reactions on HUTT in patients with exertional leg pain than that in patients without (p = 0.013). When the fractal dimension of time curves were compared, FMF patients exhibited significantly lower diastolic blood pressure parameters than controls in response to HUTT. Cardiovascular autonomic dysfunction in children with FMF is not prominent. Particularly, patients with exertional leg pain are more prone to have dysautonomic features. Further studies are needed to elucidate the exact mechanisms leading to impaired cardiac autonomic functions in FMF.
Literature
1.
go back to reference Samuels J, Ozen S (2006) Familial Mediterranean fever and the other autoinflammatory syndromes: evaluation of the patient with recurrent fever. Curr Opin Rheumatol 18:108–117CrossRefPubMed Samuels J, Ozen S (2006) Familial Mediterranean fever and the other autoinflammatory syndromes: evaluation of the patient with recurrent fever. Curr Opin Rheumatol 18:108–117CrossRefPubMed
2.
go back to reference Balow JE Jr, Shelton DA, Orsborn A et al (1997) A high-resolution genetic map of the familial Mediterranean fever candidate region allows identification of haplotype-sharing among ethnic groups. Genomics 44:280–291CrossRefPubMed Balow JE Jr, Shelton DA, Orsborn A et al (1997) A high-resolution genetic map of the familial Mediterranean fever candidate region allows identification of haplotype-sharing among ethnic groups. Genomics 44:280–291CrossRefPubMed
3.
go back to reference Zemer D, Pras M, Sohar E et al (1986) Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. N Engl J Med 314:1001–1005CrossRefPubMed Zemer D, Pras M, Sohar E et al (1986) Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. N Engl J Med 314:1001–1005CrossRefPubMed
4.
go back to reference Zemer D, Revach M, Pras M et al (1974) A controlled trial of colchicine in preventing attacks of familial Mediterranean fever. N Engl J Med 291:932–934CrossRefPubMed Zemer D, Revach M, Pras M et al (1974) A controlled trial of colchicine in preventing attacks of familial Mediterranean fever. N Engl J Med 291:932–934CrossRefPubMed
6.
go back to reference Oner A, Erdoğan O, Demircin G et al (2003) Efficacy of colchicine therapy in amyloid nephropathy of familial Mediterranean fever. Pediatr Nephrol 18:521–526PubMed Oner A, Erdoğan O, Demircin G et al (2003) Efficacy of colchicine therapy in amyloid nephropathy of familial Mediterranean fever. Pediatr Nephrol 18:521–526PubMed
7.
go back to reference Bagci S, Toy B, Tuzun A et al (2004) Continuity of cytokine activation in patients with familial Mediterranean fever. Clin Rheumatol 23:333–337CrossRefPubMed Bagci S, Toy B, Tuzun A et al (2004) Continuity of cytokine activation in patients with familial Mediterranean fever. Clin Rheumatol 23:333–337CrossRefPubMed
8.
go back to reference Kiraz S, Ertenli I, Arici M, Calguneri M, Haznedaroglu I, Celik I, Pay S, Kirazli S (1988) Effects of colchicine on inflammatory cytokines and selectins in familial Mediterranean fever. Clin Exp Rheumatol 16:721–724 Kiraz S, Ertenli I, Arici M, Calguneri M, Haznedaroglu I, Celik I, Pay S, Kirazli S (1988) Effects of colchicine on inflammatory cytokines and selectins in familial Mediterranean fever. Clin Exp Rheumatol 16:721–724
9.
go back to reference TASK FORCE OF THE EUROPEAN SOCIETY OF CARDIOLOGY AND THE NORTH AMERICAN SOCIETY OF PACING AND ELECTROPHYSIOLOGY (1996) Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Eur Heart J 17:354–381CrossRef TASK FORCE OF THE EUROPEAN SOCIETY OF CARDIOLOGY AND THE NORTH AMERICAN SOCIETY OF PACING AND ELECTROPHYSIOLOGY (1996) Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Eur Heart J 17:354–381CrossRef
10.
go back to reference Rozenbaum M, Naschitz JE, Yudashkin M, Rosner I, Sabo E, Shaviv N, Gaitini L, Zuckerman E, Yeshurun D (2002) Cardiovascular autonomic dysfunction in familial Mediterranean fever. J Rheumatol 29:987–989PubMed Rozenbaum M, Naschitz JE, Yudashkin M, Rosner I, Sabo E, Shaviv N, Gaitini L, Zuckerman E, Yeshurun D (2002) Cardiovascular autonomic dysfunction in familial Mediterranean fever. J Rheumatol 29:987–989PubMed
11.
go back to reference Rozenbaum M, Naschitz JE, Yudashkin M, Sabo E, Shaviv N, Gaitini L, Zuckerman E, Yeshurun D, Rosner I (2004) Cardiovascular reactivity score for the assessment of dysautonomia in familial Mediterranean fever. Rheumatol Int 24:147–152CrossRefPubMed Rozenbaum M, Naschitz JE, Yudashkin M, Sabo E, Shaviv N, Gaitini L, Zuckerman E, Yeshurun D, Rosner I (2004) Cardiovascular reactivity score for the assessment of dysautonomia in familial Mediterranean fever. Rheumatol Int 24:147–152CrossRefPubMed
12.
go back to reference Nussinovitch N, Livneh A, Katz K, Langevitz P, Feld O, Nussinovitch M, Volovitz B, Lidar M, Nussinovitch U (2011) Heart rate variability in familial Mediterranean fever. Rheumatol Int 31:39–43CrossRefPubMed Nussinovitch N, Livneh A, Katz K, Langevitz P, Feld O, Nussinovitch M, Volovitz B, Lidar M, Nussinovitch U (2011) Heart rate variability in familial Mediterranean fever. Rheumatol Int 31:39–43CrossRefPubMed
13.
go back to reference Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, Migdal A, Padeh S, Pras M (1997) Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 40:1879–1885CrossRefPubMed Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, Migdal A, Padeh S, Pras M (1997) Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 40:1879–1885CrossRefPubMed
14.
go back to reference Ben-Chetrit E, Ozdogan H (2008) Non-response to colchicine in FMF—definition, causes and suggested solutions. Clin Exp Rheumatol 26(4 Suppl 50):49–51 Ben-Chetrit E, Ozdogan H (2008) Non-response to colchicine in FMF—definition, causes and suggested solutions. Clin Exp Rheumatol 26(4 Suppl 50):49–51
15.
go back to reference Pras E, Livneh A, Balow JE Jr, Pras E, Kastner DL, Pras M, Langevitz P (1998) Clinical differences between North African and Iraqi Jews with familial Mediterranean fever. Am J Med Genet 75:216–219CrossRefPubMed Pras E, Livneh A, Balow JE Jr, Pras E, Kastner DL, Pras M, Langevitz P (1998) Clinical differences between North African and Iraqi Jews with familial Mediterranean fever. Am J Med Genet 75:216–219CrossRefPubMed
16.
go back to reference Bruce RA, Kusumi F, Hosmer D (1973) Maximal oxygen intake and nomographic assessment of functional aerobic impairment in cardiovascular disease. Am Heart J 85:546–562CrossRefPubMed Bruce RA, Kusumi F, Hosmer D (1973) Maximal oxygen intake and nomographic assessment of functional aerobic impairment in cardiovascular disease. Am Heart J 85:546–562CrossRefPubMed
17.
go back to reference Naschitz JE, Sabo E, Naschitz S et al (2001) Hemodynamic instability in chronic fatigue syndrome: indices and diagnostic significance. Semin Arthritis Rheum 31:199–208CrossRefPubMed Naschitz JE, Sabo E, Naschitz S et al (2001) Hemodynamic instability in chronic fatigue syndrome: indices and diagnostic significance. Semin Arthritis Rheum 31:199–208CrossRefPubMed
18.
go back to reference Naschitz JE, Sabo E, Naschitz S et al (2002) Fractal analysis and recurrence quantification analysis of heart rate and pulse transit time for diagnosing chronic fatigue syndrome. Clin Auton Res 12:262–274CrossRef Naschitz JE, Sabo E, Naschitz S et al (2002) Fractal analysis and recurrence quantification analysis of heart rate and pulse transit time for diagnosing chronic fatigue syndrome. Clin Auton Res 12:262–274CrossRef
19.
go back to reference Thomas DE, Exton SA, Yousef ZR (2010) Heart rate deceleration after exercise predicts patients most likely to respond to cardiac resynchronisation therapy. Heart 96:1385–1389CrossRefPubMed Thomas DE, Exton SA, Yousef ZR (2010) Heart rate deceleration after exercise predicts patients most likely to respond to cardiac resynchronisation therapy. Heart 96:1385–1389CrossRefPubMed
20.
go back to reference Ardic I, Kaya MG, Yarlioglues M, Dogdu O, Celikbilek M, Akpek M, Akyol L, Torun E (2011) Rheumatol Int 31:121–125, Assessment of heart rate recovery index in patients with familial Mediterranean feverCrossRefPubMed Ardic I, Kaya MG, Yarlioglues M, Dogdu O, Celikbilek M, Akpek M, Akyol L, Torun E (2011) Rheumatol Int 31:121–125, Assessment of heart rate recovery index in patients with familial Mediterranean feverCrossRefPubMed
21.
go back to reference Canpolat U, Dural M, Aytemir K, Akdoğan A, Kaya EB, Sahiner L, Yalçin U, Canpolat AG, Calgüneri M, Kabakçi G, Tokgözoğlu L, Oto A (2012) Evaluation of various cardiac autonomic indices in patients with familial Mediterranean fever on colchicine treatment. Auton Neurosci 167:70–74CrossRefPubMed Canpolat U, Dural M, Aytemir K, Akdoğan A, Kaya EB, Sahiner L, Yalçin U, Canpolat AG, Calgüneri M, Kabakçi G, Tokgözoğlu L, Oto A (2012) Evaluation of various cardiac autonomic indices in patients with familial Mediterranean fever on colchicine treatment. Auton Neurosci 167:70–74CrossRefPubMed
22.
go back to reference Koca B, Kasapçopur O, Bakari S, Sönmez E, Oztunç F, Eroğlu AG, Saltik L, Calay O (2012) QT dispersion and cardiac involvement in children with Familial Mediterranean fever. Cardiol Young 22(4):404–409CrossRefPubMed Koca B, Kasapçopur O, Bakari S, Sönmez E, Oztunç F, Eroğlu AG, Saltik L, Calay O (2012) QT dispersion and cardiac involvement in children with Familial Mediterranean fever. Cardiol Young 22(4):404–409CrossRefPubMed
23.
go back to reference Topal F, Tanindi A, Kurtoglu HG, Akbulut S, Kucukazman M, Topal FE (2011) QT dispersion is not increased in familial Mediterranean fever. J Int Med Res 39(5):2006–2011CrossRefPubMed Topal F, Tanindi A, Kurtoglu HG, Akbulut S, Kucukazman M, Topal FE (2011) QT dispersion is not increased in familial Mediterranean fever. J Int Med Res 39(5):2006–2011CrossRefPubMed
24.
go back to reference Nussinovitch U, Kaminer K, Nussinovitch M, Volovitz B, Lidar M, Nussinovitch N, Livneh A (2012) QT interval variability in familial Mediterranean fever: a study in colchicine-responsive and colchicine-resistant patients. Clin Rheumatol 31(5):795–799CrossRefPubMed Nussinovitch U, Kaminer K, Nussinovitch M, Volovitz B, Lidar M, Nussinovitch N, Livneh A (2012) QT interval variability in familial Mediterranean fever: a study in colchicine-responsive and colchicine-resistant patients. Clin Rheumatol 31(5):795–799CrossRefPubMed
25.
go back to reference Nussinovitch U, Livneh A, Volovitz B, Nussinovitch M, Ben-Zvi I, Lidar M, Nussinovitch N (2012) Normal QT dispersion in colchicine-resistant familial Mediterranean fever (FMF). Clin Rheumatol 31(7):1093–1096CrossRefPubMed Nussinovitch U, Livneh A, Volovitz B, Nussinovitch M, Ben-Zvi I, Lidar M, Nussinovitch N (2012) Normal QT dispersion in colchicine-resistant familial Mediterranean fever (FMF). Clin Rheumatol 31(7):1093–1096CrossRefPubMed
26.
go back to reference Janse van Rensburg DC, Ker JA, Grant CC, Fletcher L (2012) Autonomic impairment in rheumatoid arthritis. Int J Rheum Dis 15:419–426CrossRefPubMed Janse van Rensburg DC, Ker JA, Grant CC, Fletcher L (2012) Autonomic impairment in rheumatoid arthritis. Int J Rheum Dis 15:419–426CrossRefPubMed
27.
go back to reference Aydemir M, Yazisiz V, Basarici I, Avci AB, Erbasan F, Belgi A, Terzioglu E (2010) Cardiac autonomic profile in rheumatoid arthritis and systemic lupus erythematosus. Lupus 19:255–261CrossRefPubMed Aydemir M, Yazisiz V, Basarici I, Avci AB, Erbasan F, Belgi A, Terzioglu E (2010) Cardiac autonomic profile in rheumatoid arthritis and systemic lupus erythematosus. Lupus 19:255–261CrossRefPubMed
28.
go back to reference Newton JL, Frith J, Powell D, Hackett K, Wilton K, Bowman S, Price E, Pease C, Andrews J, Emery P, Hunter J, Gupta M, Vadivelu S, Giles I, Isenberg D, Lanyon P, Jones A, Regan M, Cooper A, Moots R, Sutcliffe N, Bombardieri M, Pitzalis C, McLaren J, Young-Min S, Dasgupta B, Griffiths B, Lendrem D, Mitchell S, Ng WF, UK primary Sjögren’s syndrome registry (2012) Autonomic symptoms are common and are associated with overall symptom burden and disease activity in primary Sjogren’s syndrome. Ann Rheum Dis 71:1973–1979CrossRefPubMedPubMedCentral Newton JL, Frith J, Powell D, Hackett K, Wilton K, Bowman S, Price E, Pease C, Andrews J, Emery P, Hunter J, Gupta M, Vadivelu S, Giles I, Isenberg D, Lanyon P, Jones A, Regan M, Cooper A, Moots R, Sutcliffe N, Bombardieri M, Pitzalis C, McLaren J, Young-Min S, Dasgupta B, Griffiths B, Lendrem D, Mitchell S, Ng WF, UK primary Sjögren’s syndrome registry (2012) Autonomic symptoms are common and are associated with overall symptom burden and disease activity in primary Sjogren’s syndrome. Ann Rheum Dis 71:1973–1979CrossRefPubMedPubMedCentral
29.
go back to reference Straub RH, Zeuner M, Lock G, Rath H, Hein D, Scholmerich J, Lang B (1996) Autonomic and sensorimotor neuropathy in patients with systemic lupus erythematosus and systemic sclerosis. J Rheumatol 23:87–92PubMed Straub RH, Zeuner M, Lock G, Rath H, Hein D, Scholmerich J, Lang B (1996) Autonomic and sensorimotor neuropathy in patients with systemic lupus erythematosus and systemic sclerosis. J Rheumatol 23:87–92PubMed
30.
go back to reference Demir H, Keleştimur F, Tunç M, Kirnap M, Ozügül Y (1999) Hypothalamo-pituitary-adrenal axis and growth hormone axis in patients with rheumatoid arthritis. Scand J Rheumatol 28:41–46CrossRefPubMed Demir H, Keleştimur F, Tunç M, Kirnap M, Ozügül Y (1999) Hypothalamo-pituitary-adrenal axis and growth hormone axis in patients with rheumatoid arthritis. Scand J Rheumatol 28:41–46CrossRefPubMed
31.
go back to reference Korkmaz C (2006) Is there a hypothalamic-pituitary-adrenal axis dysfunction in patients with familial Mediterranean fever? Clin Rheumatol 25:606–607CrossRefPubMed Korkmaz C (2006) Is there a hypothalamic-pituitary-adrenal axis dysfunction in patients with familial Mediterranean fever? Clin Rheumatol 25:606–607CrossRefPubMed
32.
go back to reference Korkmaz C, Colak O, Alatas O, Ozarslan A, Ergul B (2002) Early blunted cortisol response to insulin induced hypoglycaemia in familial Mediterranean fever. Clin Exp Rheumatol 20(4 Suppl 26):S8–S12PubMed Korkmaz C, Colak O, Alatas O, Ozarslan A, Ergul B (2002) Early blunted cortisol response to insulin induced hypoglycaemia in familial Mediterranean fever. Clin Exp Rheumatol 20(4 Suppl 26):S8–S12PubMed
33.
go back to reference Huppertz HI, Michels H (1988) The metaraminol provocation test in the diagnosis of familial Mediterranean fever. Monatsschr Kinderheilkd 136:243–245PubMed Huppertz HI, Michels H (1988) The metaraminol provocation test in the diagnosis of familial Mediterranean fever. Monatsschr Kinderheilkd 136:243–245PubMed
34.
go back to reference Peterson GM, McGinty JF (1988) Direct neurotoxic effects of colchicine on cholinergic neurons in medial septum and striatum. Neurosci Lett 94:46–51CrossRefPubMed Peterson GM, McGinty JF (1988) Direct neurotoxic effects of colchicine on cholinergic neurons in medial septum and striatum. Neurosci Lett 94:46–51CrossRefPubMed
35.
go back to reference Ginn SR, Peterson GM (1992) Studies related to the use of colchicine as a neurotoxin in the septohippocampal cholinergic system. Brain Res 590:144–152CrossRefPubMed Ginn SR, Peterson GM (1992) Studies related to the use of colchicine as a neurotoxin in the septohippocampal cholinergic system. Brain Res 590:144–152CrossRefPubMed
37.
go back to reference Adams DH, Nash GB (1996) Disturbance of leucocyte circulation and adhesion to the endothelium as factors in circulatory pathology. Br J Anaesth 77:17–31CrossRefPubMed Adams DH, Nash GB (1996) Disturbance of leucocyte circulation and adhesion to the endothelium as factors in circulatory pathology. Br J Anaesth 77:17–31CrossRefPubMed
38.
go back to reference Vallejo M, Martínez-Martínez LA, Grijalva-Quijada S, Olguín-Ruvalcaba HM, Salas E, Hermosillo AG, Cárdenas M, Martínez-Lavín M (2013) Prevalence of fibromyalgia in vasovagal syncope. J Clin Rheumatol 19:111–114CrossRefPubMed Vallejo M, Martínez-Martínez LA, Grijalva-Quijada S, Olguín-Ruvalcaba HM, Salas E, Hermosillo AG, Cárdenas M, Martínez-Lavín M (2013) Prevalence of fibromyalgia in vasovagal syncope. J Clin Rheumatol 19:111–114CrossRefPubMed
39.
go back to reference da Cunha Ribeiro RP, Roschel H, Artioli GG, Dassouki T, Perandini LA, Calich AL, de Sá Pinto AL, Lima FR, Bonfá E, Gualano B (2011) Cardiac autonomic impairment and chronotropic incompetence in fibromyalgia. Arthritis Res Ther 13(6):R190CrossRefPubMedPubMedCentral da Cunha Ribeiro RP, Roschel H, Artioli GG, Dassouki T, Perandini LA, Calich AL, de Sá Pinto AL, Lima FR, Bonfá E, Gualano B (2011) Cardiac autonomic impairment and chronotropic incompetence in fibromyalgia. Arthritis Res Ther 13(6):R190CrossRefPubMedPubMedCentral
40.
go back to reference Kulshreshtha P, Deepak KK (2013) Autonomic nervous system profile in fibromyalgia patients and its modulation by exercise: a mini review. Clin Physiol Funct Imaging 33:83–91CrossRefPubMed Kulshreshtha P, Deepak KK (2013) Autonomic nervous system profile in fibromyalgia patients and its modulation by exercise: a mini review. Clin Physiol Funct Imaging 33:83–91CrossRefPubMed
Metadata
Title
Cardiac autonomic functions in children with familial Mediterranean fever
Authors
Murat Şahin
Mustafa Kır
Balahan Makay
Pembe Keskinoğlu
Elçin Bora
Erbil Ünsal
Nurettin Ünal
Publication date
01-05-2016
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 5/2016
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-014-2714-z

Other articles of this Issue 5/2016

Clinical Rheumatology 5/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.